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Science & SocietyRNAi offers opportunities to generate new traits in
genetically modified (GM) plants. Instead of expressing
novel proteins, RNAi-based GM plants reduce target
gene expression. Silencing of off-target genes may
trigger unintended effects, and identifying these genes
would facilitate risk assessment. However, using bioin-
formatics alone is not reliable, due to the lack of genomic
data and insufficient knowledge of mechanisms govern-
ing mRNA–small (s)RNA interactions.
Background
Technological advances in genetics and genomics led to the
development of new types GM plant in which target genes
are silenced through RNAi. RNAi is a conserved mecha-
nism that relies on the production of sRNA (20–30 nucleo-
tides in size), which promotes degradation or translation
repression of homologous mRNA. In the common eukary-
otic ancestor, RNAi was probably meant to target molecu-
lar parasites, such as viruses or transposons [1], but
subsequently evolved to act on various aspects of gene
regulation or genome structure [2]. RNAi can occur natu-
rally, as a result of natural modifications of gene copy
number or genetic arrangements. Plant breeders have
already selected for natural RNAi-mediated traits, such
as seed coat colour or low glutelin level, in soybean and rice,
respectively [3], through conventional breeding without
the aid of any transgenic manipulation.
However, transgenic RNAi has emerged as a powerful
and innovative genetic tool for biological research. It has
been utilised in fundamental research for the assessment
of gene functions, and in various fields of applied research,
such as human and/or veterinary medicine, and agricul-
ture. Given its potential to control gene expression, RNAi
offers new opportunities for plant breeding (Box 1), and
is being used to alter agronomic and compositional char-
acteristics in GM plants (e.g., nutritional enrichment,0167-7799/
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[4]. RNAi-based GM plants are approaching commerciali-
sation and, similar to GM plants in most jurisdictions,
will likely be subject to a risk analysis before regulatory
approval. Several international risk assessment bodies
involved in the pre-market risk assessment of GM plants
are currently considering whether existing approaches are
appropriate or need to be refined for RNAi-based GM
plants (Table 1). Here, we discuss possible risks to human
and animal health and the environment associated with
the silencing of off-target genes, and possible strategies
to assess these risks.
Risk assessment considerations for RNAi-based GM
plants
Risks associated with the intended changes in current GM
plants are usually related to the newly expressed proteins
(e.g., possible toxicity and allergenicity). Given that most
RNAi strategies aim to reduce the amount of endogenous
proteins, such risks are not necessarily relevant for RNAi-
based GM plants. However, the decreased expression of
a target gene may have safety implications in particular
cases (e.g., if a substrate of a silenced enzyme accumulates
to toxic levels).
Risks more specifically associated with RNAi strategies
exist. Given that RNAi activity is based on the pairing
between sRNA and mRNA, not only the target gene, but
also off-target genes that produce mRNA with sufficient
nucleotide sequence complementarity to the sRNA could be
silenced [5]. Owing to the conserved nature of RNAi [6],
target and off-target genes could be silenced in both the
RNAi-based GM plant and organisms consuming and/or
infecting that plant. These organisms include target pests,
in the case of host-delivered RNAi, and nontarget organ-
isms (NTOs). Silencing of target and off-target genes in the
GM plant and NTOs could lead to adverse effects, which
require assessment. However, the likelihood of silencing
a given gene will depend on the ability of the sRNA to be
a substrate for the RNAi machinery of the recipient organ-
ism. Indeed, RNAi machinery varies among species [7] and
there is convincing evidence for only a few organisms (e.g.,
nematodes and insects) that the plant-produced sRNA
uses host RNAi machinery [8]. It should be noted thatTrends in Biotechnology, March 2015, Vol. 33, No. 3 145
Box 1. Strengths and limitations of RNAi as a tool for plant breeding
Strengths
 The efficacy of silencing of a target gene via RNAi varies from one
GM plant to another [13], which allows for the identification of
plants showing a range of decreased target gene expression. This is
particularly interesting when complete silencing of the target gene
is not viable or induces an undesirable phenotype. This may be
particularly interesting for the reduction of antinutrient levels in GM
plants.
 The silencing of a target gene via RNAi can be spatially and/or
temporally controlled by suitable promoters, in contrast to a
conventional gene knockout. It is possible to downregulate a gene
function in particular tissues and/or organs, while preserving it in
other tissues and/or organs or developmental stages.
 Many important crop species have genomes originating from ancestral
or recent polyploidisation events and, therefore, contain multiple
alleles of a gene; RNAi enables their simultaneous silencing [14].
 The RNAi process is, in part, ubiquitous among eukaryotes, and
double-stranded RNA or small interfering RNA (siRNA) produced by
a plant can, in some cases, silence a target gene in an organisms
feeding on or infecting that plant. This offers new opportunities for
the control of pests and plant diseases [15].
Limitations
 For reasons that are still not well understood, some mRNAs appear
difficult to silence through RNAi [13].
 Given that rules governing the pairing of sRNAs with target
mRNAs are not fully known, off-target gene effects are
possible.
 Besides triggering the degradation or translation repression of
homologous mRNA, RNAi also induces the methylation of homo-
logous DNA, including the transcribed region of RNAi transgene
itself. DNA methylation sometimes spreads into adjacent se-
quences such as the transgene promoter, which could eventually
reduce RNAi efficiency over generations.
 Given that RNAi relies on the sequence-specific pairing of sRNA
to mRNA, mutations arising in the target mRNA in the middle
of its complementary region to the sRNA guide could prevent
targeting this mRNA, sometimes without changing the translated
amino acid sequence (silent mutations). Such mutations act in
a dominant manner, which increases the likelihood of occurrence
in nature. This is of particular importance for RNAi-mediated
pest or disease control if RNAi relies on the production of a
single artificial miRNA and not on a population of siRNA. For
example, mutations in the target sequence enable viruses to
circumvent silencing mediated by an artificial miRNA produced in
GM plants.
 Mutations arising in an endogenous mRNA, close, but not
perfectly homologous to the target mRNA, could create a
complementary region. Having a novel target in GM plants
would dilute the effect of transgene-derived sRNA(s) on the
expected target. Such mutations would also act in a dominant
manner.
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reduction of in vivo gene expression. Even in the event
that the expression level of a gene is reduced, this may
not necessarily result in detectable phenotypic changes.
Only a fraction of such unexpected phenotypic changes
may translate into adverse effects, depending on the func-
tion of the silenced off-target gene.
Given that silencing off-target genes within the GM
plant or in organisms infecting or feeding on the plant
may, in some cases, constitute a new risk for humans, other
animals, or the environment, such risks should be properly
assessed and managed. Genome-wide bioinformatic anal-
yses of sequence complementarity between the expressed
sRNA(s) and all known mRNAs would help to identify
potential off-target genes in the GM plant itself and in
NTOs. However, there are several limitations to such
analyses. Despite the large number of sequenced genomes,
the genomes of many crop plants remain unknown. In
addition, for those genomes that have been sequenced,
information is still limited, because variable fractions,
usually comprising centromeric or highly repetitive parts
of the genome, remain unknown.
For most sequenced species, only a reference genome is
sequenced and assembled to such an extent that it could
be considered relatively complete. Given that the sRNA–
mRNA interaction relies on a limited sequence length, any
sequence variability between varieties may change the
spectrum of potential target and off-target genes. Owing
to the lack of genome sequence information for all the
varieties in which the RNAi-based transformation event
may be introduced, it will not be possible to perform a
complete search of all potential off-target genes. In addi-
tion, because various species belonging to different taxa
can be exposed to an RNAi-based GM plant [9], the limited
availability of genome data for non-model species further146reduces the usefulness of a bioinformatics-based approach
for the risk assessment of NTOs. Owing to these limita-
tions, bioinformatic analyses are likely to be of limited
value to predict off-target gene effects in the GM plant or in
NTOs exposed to that plant in most cases [10]. However,
bioinformatics could inform the species selection process by
identifying groups of NTOs that are potentially sensitive.
A complementary approach to bioinformatics analyses
could be to use new molecular techniques, such as parallel
analysis of RNA ends (PARE) [11]. PARE relies on the
ability of cleaved RNAs, such as those resulting from
sRNA-guided cleavage of a mRNA by the RNAi machinery,
to ligate to RNA adaptors by virtue of the absence of a cap
at their 50 end (capped mRNAs cannot be ligated). Sequenc-
ing libraries of cleaved mRNAs from both the RNAi-based
GM plant and an adequate comparator would allow the
determination of the intended and unintended targets of
the sRNA(s) produced by the RNAi construct. However,
because the population of mRNAs depends on the cell
types, organs, developmental stages, or environmental
conditions, a complete evaluation of possible off-target
genes remains challenging. Moreover, this inventory of
unintended targets of the sRNA(s) produced by the RNAi
construct would be restricted to the GM plant itself and not
likely feasible in NTOs.
Concluding remarks and future perspectives
RNAi is an emerging technology that offers new opportu-
nities to plant breeders. The risk assessment of RNAi-
based GM plants presents some peculiarities compared
with that of currently commercialised GM plants. Allerge-
nicity assessment of newly expressed proteins, for exam-
ple, will not be meaningful for RNAi-based GM plants. By
contrast, the evaluation of the potential risk associated
with the silencing of an off-target gene is specific to this
Table 1. Risk assessment considerations on RNAi-based GM plants and derived food and/or feed products from international
bodies
Authority and/or institute Web address
Center for Environmental Risk Assessment (CERA) http://cera-gmc.org/docs/cera_publications/pub_08_2011.pdf
European Food Safety Authority (EFSA) http://www.efsa.europa.eu/fr/events/event/140604.htm
Food Standards Australia New Zealand (FSANZ) http://www.foodstandards.govt.nz/consumer/gmfood/Documents/
Heinemann%20Response%20210513.pdf
US Environmental Protection Agency (US EPA) http://www.epa.gov/scipoly/sap/meetings/2014/january/012814minutes.pdf
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significantly impact agronomic performance and crop qual-
ity can be detected, and counter-selected, by the breeder
during the breeding process, as is the case for the develop-
ment of any new trait in GM and conventional plants, but
other unintended effects could persist in the final RNAi-
based plant. The identification of such potential off-target
effects could be achieved by the identification of mRNAs
that exhibit limited, although significant, complementary
to the sRNA molecules produced by the RNAi construct.
Although new bioinformatics [12] and molecular techni-
ques [11] may help to evaluate the spectrum of off-target
sequences, these analysis are currently of limited value for
the risk assessment for three reasons: (i) suitable genome
data are available only for a limited number of species; (ii)
rules governing efficient mRNA and/or sRNA recognition
by the RNAi machinery are incompletely understood; and
(iii) the capacity of plant sRNA to trigger silencing in non-
plant organisms is not always clear and has been estimated
for only a few species. Progress in basic research on RNAi
mechanisms, production of suitable genome data for rele-
vant species, and design of efficient algorithms to make more
reliable predictions will help to fill these technological
gaps. This new information and the associated tools will
not only facilitate the risk assessment of RNAi-based GM
plants, but may also have a more general impact on the
evaluation of potential risk associated with the production
of sRNA in GM or non-GM plants. Despite these technical
limitations and possible advancements, the risk assessment
strategies followed for current GM plants, based on the
comparative analysis of the molecular, compositional,
and agronomic/phenotypic characteristics of the GM plant
and its conventional counterpart, remain applicable and
adequate for the evaluation of RNAi-based GM plants.
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